WO2023096373A1 - Ensemble d'amorces de matériau d'étiquetage fluorescent pour détection multiple dans un procédé d'amplification isotherme à médiation par boucle et procédé de diagnostic moléculaire l'utilisant - Google Patents
Ensemble d'amorces de matériau d'étiquetage fluorescent pour détection multiple dans un procédé d'amplification isotherme à médiation par boucle et procédé de diagnostic moléculaire l'utilisant Download PDFInfo
- Publication number
- WO2023096373A1 WO2023096373A1 PCT/KR2022/018724 KR2022018724W WO2023096373A1 WO 2023096373 A1 WO2023096373 A1 WO 2023096373A1 KR 2022018724 W KR2022018724 W KR 2022018724W WO 2023096373 A1 WO2023096373 A1 WO 2023096373A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- primer
- loop
- primer set
- multiple detection
- fluorescent
- Prior art date
Links
- 238000007397 LAMP assay Methods 0.000 title claims abstract description 46
- 238000001514 detection method Methods 0.000 title claims abstract description 29
- 238000000034 method Methods 0.000 title claims abstract description 20
- 239000007850 fluorescent dye Substances 0.000 title claims abstract description 14
- 238000003745 diagnosis Methods 0.000 title claims abstract description 13
- 238000001215 fluorescent labelling Methods 0.000 title claims abstract description 11
- 239000000463 material Substances 0.000 title claims abstract description 10
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 14
- 108090000623 proteins and genes Proteins 0.000 claims description 18
- 241000700605 Viruses Species 0.000 claims description 12
- 241001678559 COVID-19 virus Species 0.000 claims description 10
- 239000012472 biological sample Substances 0.000 claims description 5
- 239000003550 marker Substances 0.000 claims description 5
- 238000010839 reverse transcription Methods 0.000 claims description 4
- 101150001779 ORF1a gene Proteins 0.000 claims description 3
- 239000000126 substance Substances 0.000 claims description 2
- 108020004414 DNA Proteins 0.000 description 27
- 230000003321 amplification Effects 0.000 description 17
- 238000003199 nucleic acid amplification method Methods 0.000 description 17
- 238000006243 chemical reaction Methods 0.000 description 15
- 241000004176 Alphacoronavirus Species 0.000 description 12
- 239000002773 nucleotide Substances 0.000 description 12
- 125000003729 nucleotide group Chemical group 0.000 description 12
- 238000003757 reverse transcription PCR Methods 0.000 description 6
- 238000011161 development Methods 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 239000000523 sample Substances 0.000 description 5
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 4
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 4
- 108091034117 Oligonucleotide Proteins 0.000 description 4
- 238000003752 polymerase chain reaction Methods 0.000 description 4
- 238000003753 real-time PCR Methods 0.000 description 4
- 108091028043 Nucleic acid sequence Proteins 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 108020004707 nucleic acids Proteins 0.000 description 3
- 102000039446 nucleic acids Human genes 0.000 description 3
- 150000007523 nucleic acids Chemical class 0.000 description 3
- 230000037452 priming Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- VGIRNWJSIRVFRT-UHFFFAOYSA-N 2',7'-difluorofluorescein Chemical compound OC(=O)C1=CC=CC=C1C1=C2C=C(F)C(=O)C=C2OC2=CC(O)=C(F)C=C21 VGIRNWJSIRVFRT-UHFFFAOYSA-N 0.000 description 2
- 241000008904 Betacoronavirus Species 0.000 description 2
- 208000035473 Communicable disease Diseases 0.000 description 2
- 208000001528 Coronaviridae Infections Diseases 0.000 description 2
- 241001461743 Deltacoronavirus Species 0.000 description 2
- 241000008920 Gammacoronavirus Species 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000012827 research and development Methods 0.000 description 2
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- 230000008685 targeting Effects 0.000 description 2
- ABZLKHKQJHEPAX-UHFFFAOYSA-N tetramethylrhodamine Chemical compound C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=CC=C1C([O-])=O ABZLKHKQJHEPAX-UHFFFAOYSA-N 0.000 description 2
- 244000052613 viral pathogen Species 0.000 description 2
- QCPFFGGFHNZBEP-UHFFFAOYSA-N 4,5,6,7-tetrachloro-3',6'-dihydroxyspiro[2-benzofuran-3,9'-xanthene]-1-one Chemical compound O1C(=O)C(C(=C(Cl)C(Cl)=C2Cl)Cl)=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 QCPFFGGFHNZBEP-UHFFFAOYSA-N 0.000 description 1
- COCMHKNAGZHBDZ-UHFFFAOYSA-N 4-carboxy-3-[3-(dimethylamino)-6-dimethylazaniumylidenexanthen-9-yl]benzoate Chemical compound C=12C=CC(=[N+](C)C)C=C2OC2=CC(N(C)C)=CC=C2C=1C1=CC(C([O-])=O)=CC=C1C(O)=O COCMHKNAGZHBDZ-UHFFFAOYSA-N 0.000 description 1
- IDLISIVVYLGCKO-UHFFFAOYSA-N 6-carboxy-4',5'-dichloro-2',7'-dimethoxyfluorescein Chemical compound O1C(=O)C2=CC=C(C(O)=O)C=C2C21C1=CC(OC)=C(O)C(Cl)=C1OC1=C2C=C(OC)C(O)=C1Cl IDLISIVVYLGCKO-UHFFFAOYSA-N 0.000 description 1
- BZTDTCNHAFUJOG-UHFFFAOYSA-N 6-carboxyfluorescein Chemical compound C12=CC=C(O)C=C2OC2=CC(O)=CC=C2C11OC(=O)C2=CC=C(C(=O)O)C=C21 BZTDTCNHAFUJOG-UHFFFAOYSA-N 0.000 description 1
- 239000012099 Alexa Fluor family Substances 0.000 description 1
- 241000272875 Ardeidae Species 0.000 description 1
- 241000008921 Avian coronavirus Species 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 241000112287 Bat coronavirus Species 0.000 description 1
- 241000639360 Bat coronavirus 1 Species 0.000 description 1
- 241000972317 Bat coronavirus CDPHE15 Species 0.000 description 1
- 241000731616 Bat coronavirus HKU10 Species 0.000 description 1
- 241000008922 Beluga Whale coronavirus SW1 Species 0.000 description 1
- 241000008905 Betacoronavirus 1 Species 0.000 description 1
- 241000711573 Coronaviridae Species 0.000 description 1
- 241001123928 Coronavirus HKU15 Species 0.000 description 1
- 238000000018 DNA microarray Methods 0.000 description 1
- 230000006820 DNA synthesis Effects 0.000 description 1
- 241000283323 Delphinapterus leucas Species 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241000856856 Duck coronavirus Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241001123922 Hedgehog coronavirus 1 Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 241000711467 Human coronavirus 229E Species 0.000 description 1
- 241001109669 Human coronavirus HKU1 Species 0.000 description 1
- 241000482741 Human coronavirus NL63 Species 0.000 description 1
- 102100034343 Integrase Human genes 0.000 description 1
- 208000025370 Middle East respiratory syndrome Diseases 0.000 description 1
- 241000127282 Middle East respiratory syndrome-related coronavirus Species 0.000 description 1
- 241000008903 Miniopterus bat coronavirus HKU8 Species 0.000 description 1
- 241000972316 Mink coronavirus 1 Species 0.000 description 1
- 241000008906 Murine coronavirus Species 0.000 description 1
- NULAJYZBOLVQPQ-UHFFFAOYSA-N N-(1-naphthyl)ethylenediamine Chemical compound C1=CC=C2C(NCCN)=CC=CC2=C1 NULAJYZBOLVQPQ-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 241000008909 Pipistrellus bat coronavirus HKU5 Species 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 244000184734 Pyrus japonica Species 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 101710118046 RNA-directed RNA polymerase Proteins 0.000 description 1
- 241000004178 Rhinolophus bat coronavirus HKU2 Species 0.000 description 1
- 241000008907 Rousettus bat coronavirus HKU9 Species 0.000 description 1
- 241000315672 SARS coronavirus Species 0.000 description 1
- 201000003176 Severe Acute Respiratory Syndrome Diseases 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- 241000947555 Thrush coronavirus HKU12 Species 0.000 description 1
- 241000287436 Turdus merula Species 0.000 description 1
- 241000008908 Tylonycteris bat coronavirus HKU4 Species 0.000 description 1
- 108020000999 Viral RNA Proteins 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 238000005251 capillar electrophoresis Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 239000003269 fluorescent indicator Substances 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000009830 intercalation Methods 0.000 description 1
- 108010059642 isinglass Proteins 0.000 description 1
- 150000002540 isothiocyanates Chemical class 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000001823 molecular biology technique Methods 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- JGVWCANSWKRBCS-UHFFFAOYSA-N tetramethylrhodamine thiocyanate Chemical compound [Cl-].C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=C(SC#N)C=C1C(O)=O JGVWCANSWKRBCS-UHFFFAOYSA-N 0.000 description 1
- MPLHNVLQVRSVEE-UHFFFAOYSA-N texas red Chemical compound [O-]S(=O)(=O)C1=CC(S(Cl)(=O)=O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 MPLHNVLQVRSVEE-UHFFFAOYSA-N 0.000 description 1
- ANRHNWWPFJCPAZ-UHFFFAOYSA-M thionine Chemical compound [Cl-].C1=CC(N)=CC2=[S+]C3=CC(N)=CC=C3N=C21 ANRHNWWPFJCPAZ-UHFFFAOYSA-M 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
Definitions
- the present invention relates to a fluorescent labeling material primer set for multiple detection in a loop-mediated isothermal amplification method and a molecular diagnosis method using the same.
- PCR Polymerase chain reaction
- qPCR Quantitative PCR
- Diagnostic qPCR has been applied to detect nucleotides representing infectious diseases, cancers and genetic abnormalities.
- Reverse transcription PCR RT-PCR
- RT-PCR Reverse transcription PCR
- RT-PCR has the advantage of being suitable for detecting viral pathogens.
- RT-PCR requires a considerable level of equipment that cannot be used in a specific point-of-care environment, and RT-PCR has limitations in that it requires considerable resources such as trained personnel and considerable sample preparation.
- LAMP Loop-mediated isothermal amplification
- RT-LAMP Reverse transcription-LAMP
- RT-LAMP can be used to identify target nucleotides from RNA, like RT-PCR, and can therefore be used as a diagnostic method to identify the presence or absence of viral pathogens. Because LAMP is simpler, it can be performed with less equipment and sample preparation, making it more accessible for use in point-of-care settings such as clinics and emergency rooms.
- the loop-mediated isothermal amplification method simply incubates a mixture of a target gene, 4 or 6 different primers, Bst DNA polymerase, and a substrate to specifically amplify under isothermal conditions (60 to 65° C.). Next, by visually evaluating the turbidity or fluorescence of the reaction mixture stored in the reaction tube, it is possible to confirm whether the target DNA is present, that is, whether the desired target nucleotide is synthesized.
- the conventional loop-mediated isothermal amplification method has limitations in labeling due to the large number of primer sets required for the synthesis of one target, making multiplex detection difficult.
- the present invention has been devised to solve the above problems, and an object to be solved in the present invention is to minimize labeling to smoothly implement multiplex detection.
- the present invention provides a fluorescent labeling material primer set for multiple detection, which includes an external primer, an internal primer, and a loop primer, each of which includes forward and reverse primers, wherein the loop primer A fluorescent agent or a quencher is bound to each of the forward and reverse primers, but a technical feature is that different things bind to each other.
- the loop primer of the present invention i) a fluorescent agent is bound to the forward primer and a quencher is bound to the reverse primer, or ii) a quencher is bound to the forward primer and fluorescence to the reverse primer
- a fluorescent agent is bound to the forward primer and a quencher is bound to the reverse primer
- a quencher is bound to the forward primer and fluorescence to the reverse primer
- the fluorescent agent or quencher of the present invention is characterized in that it binds to the end or middle of the primer.
- the fluorescent label material primer set for multiple detection of the present invention is characterized by a technical feature for detecting SARS-CoV-2 (Severe acute respiratory syndrome coronavirus 2).
- the fluorescent marker primer set for multiple detection of the present invention targets at least two or more genes selected from the group consisting of RdRP, ORF1a, ORF1b, ORF1ab, S, E, M and N It is a technical feature that
- the loop primers of the present invention are characterized in that they include SEQ ID NOs: 7, 8, 15 and 16.
- the present invention provides a molecular diagnosis method comprising the steps of (1) separating DNA from a biological sample; (2) amplifying the target sequence included in the separated DNA by performing loop-mediated isothermal amplification using the primer set according to any one of claims 1 to 6; and (3) detecting the amplified product.
- the present invention provides a molecular diagnosis method comprising the steps of (1) extracting RNA from a virus and then performing reverse transcription to obtain DNA; (2) amplifying the target sequence included in the obtained DNA by performing loop-mediated isothermal amplification using the primer set according to any one of claims 1 to 6; and (3) detecting the amplified product.
- multiplex amplification for amplifying at least two or more target genes can be implemented through LAMP.
- LAMP method that can be implemented with simple equipment, the effect of molecular diagnosis can be maximized in the field, and more sensitive and accurate diagnosis results can be derived through multiple detection.
- FIGS. 1 to 4 are schematic diagrams showing a loop-mediated isothermal amplification process for multiplex detection according to the present invention.
- Figure 5 is a graph showing the results of double-detection LAMP
- LAMP Loop-mediated isothermal amplification
- 4 types of primers (F3, B3, FIP, BIP) are basically required for the LAMP reaction, and 2 types of primers (LF, LB) are added to improve the reaction rate to obtain the final 6 types of different bases.
- An oligonucleotide primer consisting of the sequence is required for the reaction.
- the four basic primers are composed of two outer primers and two inner primers, and the outer primers include a forward outer (F3) primer and two backward outer (B3) primers. It is composed of and serves to unwind DNA double strands during the non-cyclic step of the reaction.
- the inner primer consists of two types, a forward inner primer (FIP) and a reverse inner primer (BIP), and is composed of nucleotides corresponding to the forward and reverse nucleotide sequences to form an essential loop for LAMP. It consists of The additional two primers consist of a forward loop (LF) primer and two backward loop (LB) primers, and are attached to a base sequence to which the inner primer does not bind to perform a loop-mediated isothermal amplification reaction. accelerate Amplification of the amplified DNA product is confirmed by using a reagent for detecting fluorescence or by precipitation reaction.
- FIP forward inner primer
- BIP reverse inner primer
- a LAMP may use a set of four primers. These four primers can recognize 6 distinct sequences.
- Primers for the LAMP reaction can be internal primers (eg FIP and BIP) and external primers (eg F3 and B3).
- a LAMP reaction can be initiated by hybridization of each internal primer (eg FIP or BIP) to its respective priming site (eg F2c or B2c) on the target DNA.
- An outer primer eg, F3 or B3 secondarily hybridizes to its priming site (eg, F3c or B3c) on the target DNA and creates a novel complementary sequence that displaces DNA sequences already extended from the inner primer. Initiate synthesis.
- the result is a DNA sequence capable of forming a stem-loop structure at both ends.
- This auto-primed "dumb-bell" structure is the starting material for LAMP auto-cycling amplification.
- the LAMP reaction can also be promoted using additional primers, referred to as loop primers.
- a loop primer can hybridize to a section of the loop transcribed from a target DNA template. This additional priming promotes the LAMP reaction and, as it requires transcription of the correct starting material, can improve LAMP selectivity.
- the LAMP reaction may be carried out under isothermal conditions and at a temperature value selected within a desired range, for example, from about 60°C to about 70°C, more preferably from about 60°C to about 65°C. .
- the amplification product can be stem-loop DNA, which usually has several inverted repeats of the target. These inverted repeats usually represent cauliflower-like structures with multiple loops.
- positive amplification of DNA can be monitored in real time using intercalating dyes such as SYBR Green or EvaGreen ® .
- multiplex LAMP refers to LAMP that simultaneously detects various genes.
- the presence or absence of new coronavirus infection is confirmed by confirming the amplification products of two or more genes selected from the group consisting of RdRP, ORF1a, ORF1b, ORF1ab, S, E, M, and N genes in the sample. can determine. More preferably, two or more genes among E, N, and RdRp genes may be targeted.
- the term “inner primer” refers to a single-stranded oligonucleotide capable of binding to template DNA and acting as a starting point for synthesizing a new DNA chain.
- outer primer refers to a single-stranded oligonucleotide that binds to the template DNA outside the site where the internal primer binds to the template DNA. After the chain is elongated, strand displacement occurs due to the combination of the external primer and the template DNA, so that the previously formed chain is separated.
- loop primer means that the initial stem loop structure chain formed by binding the internal and external primers to the template DNA increases the number of loop structures, resulting in It refers to a single-stranded oligonucleotide that can act as a starting point for nucleotide synthesis, allowing the overall reaction to be accelerated.
- fluorescence refers to a nucleotide containing a fluorescent agent or the fluorescent agent itself.
- Fluorescent agents include FAM (6-carboxyfluorescein), Cy5, SYBR, Texas red, fluorescein, HEX (2',4',5',7'-tetrachloro-6-carboxy-4 ,7-dichlorofluorescein, fluorescein chlorotriazinyl, rhodamine green, rhodamine red, tetramethyl rhodamine, fluorescein isothiocyanate (FITC), Oregon green (oregon green), alexa fluor, JOE (6-Carboxy-4',5'-Dichloro-2',7'-Dimethoxyfluorescein), ROX (6-Carboxyl-XRhodamine), TET (Tetrachloro-Fluorescein) ), TRITC (tertramethylrodamine
- quencher refers to a substance that inhibits the development of fluorescence.
- a virus to be diagnosed is a corona virus.
- the coronavirus is selected from the group consisting of alphacoronavirus, betacoronavirus, deltacoronavirus, and gammacoronavirus.
- alphacoronaviruses include bat coronavirus CDPHE15, bat coronavirus HKU10, human coronavirus 229E, human coronavirus NL63, long-winged bat coronavirus 1, long-winged bat coronavirus HKU8, mink coronavirus 1, swine epidemic diarrhea virus, horseshoe bat coronavirus HKU2, and yellow bat coronavirus 512.
- betacoronaviruses examples include betacoronavirus 1, hedgehog coronavirus 1, human coronavirus HKU1, coronavirus associated with Middle East respiratory syndrome, murine coronavirus, house bat coronavirus HKU5, russet bat coronavirus HKU9, associated with severe acute respiratory syndrome. corona virus, bamboo bat coronavirus HKU4, but is not limited thereto.
- deltacoronaviruses examples include japonica corona virus HKU11, coot coronavirus HKU21, coronavirus HKU15, kinbara coronavirus HKU13, egret coronavirus HKU19, thrush coronavirus HKU12, blackbird coronavirus HKU16, and red-headed duck coronavirus HKU20. It may include, but is not limited to.
- gammacoronaviruses may include, but are not limited to, avian coronavirus, beluga coronavirus SW1. Additional examples of coronaviruses may include MERS-CoV, SARS-CoV, and SARS-CoV-2. In some examples, the coronavirus may be SARS-CoV-2. That is, it is possible to diagnose viruses at the molecular level without limitation for viruses with known marker genes as previously known viruses.
- reagents such as reverse transcriptase, DNA polymerase, dNTPs and buffers may be included.
- DNA polymerase according to an embodiment of the present invention, Bst polymerase, GspSSD DNA polymerase, etc. may be used, but is not limited thereto.
- R-LAMP Rapid point-of-care detection of SARS-CoV-2 using reverse transcription loop-mediated isothermal amplification
- amplification/presence of a gene to be amplified/confirmed can be confirmed by binding a fluorescent agent or a quencher to each of the forward and reverse primers of the loop primer.
- the primary replication of the target gene is performed to form a loop, and a forward loop primer (fluorescent agent binding, FLPQ) and a reverse loop primer (quencher binding, FLPR) complementary thereto are present ( 1), a forward loop primer (linked with a fluorophore) is located in the loop of the copied genetic material (see FIG. 2), and then DNA synthesis occurs as a polymerase binds to a reverse loop primer (linked with a quencher, FLPQ).
- the fluorescent agent develops color as it is separated (see FIG.
- the forward and reverse loop primers bind to maintain a state in which the quencher suppresses fluorescence, and as the amplification proceeds according to the LAMP reaction, the forward loop primer becomes part of the amplification product, and as it binds to the product, it is separated from the quencher and fluorescence emit a signal As this process is repeated, as the target gene having the loop is finally amplified, the degree of color development of the fluorescent agent increases, thereby confirming the amplification of the target gene (see FIG. 4).
- the target genes of LAMP performed in the examples were ORF1ab and N, which are representative markers of SARS-CoV-2, and B-actin was used as a control to confirm that they were human genes.
- the nucleotide sequence of the primer for ORF1ab is shown in Table 1 below. Bases marked in dark color in the base sequence are portions to which a fluorescent or quencher is attached, and are the same below. For fluorescence of ORF1ab, FAM was used.
- the nucleotide sequence of the primer for N is as shown in Table 2 below. For N fluorescence, Cy5 was used.
- Multi-detection-LAMP A mixture was prepared with the composition shown in Table 4, and then primers having the composition shown in Table 5 (double-detection) or Table 6 (triple-detection) were added to the mixture and mixed. And LAMP was performed by reacting at a temperature of 65 °C for 40 minutes in CFX96TM (BIO-RAD).
- each target gene was amplified through FAM fluorescence signal (ORF1ab label, see (A) in FIG. 5) and Cy5 fluorescence signal (N label, see (B) in FIG. 5). Confirmed. In addition, the fidelity of the amplification pattern and simultaneous amplification was confirmed by simultaneously confirming the two fluorescence signals (see FIG. 5(C)).
- the molecular diagnosis method includes (1) isolating DNA from a biological sample; (2) amplifying the target sequence included in the separated DNA by performing loop-mediated isothermal amplification using the primer set according to any one of claims 1 to 6; and (3) detecting the amplified product.
- the molecular diagnosis method when the biological sample is a virus, (1) extracting RNA from the virus and then reverse transcribing it to obtain DNA; (2) amplifying the target sequence included in the obtained DNA by performing loop-mediated isothermal amplification using the primer set according to any one of claims 1 to 6; and (3) detecting the amplified product.
- the biological sample in step (1) is preferably a body fluid, cell, etc. containing DNA or RNA collected from humans, non-human animals and plants, and the sample contains a specific virus or the nucleic acid of the virus. there is.
- viruses since nucleic acids are included in RNA, a process of reverse transcription of viral RNA into DNA may be required.
- Amplification in step (2) means performing LAMP according to the present invention, and preferably refers to performing LAMP using the primer set according to the present invention.
- the detection of the amplified nucleic acid in step (3) may use at least one method selected from the group consisting of capillary electrophoresis, DNA chip, gel electrophoresis, radioactivity measurement, fluorescence measurement, and phosphorescence measurement, but is not limited thereto.
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
La présente invention concerne un ensemble d'amorces de matériau d'étiquetage fluorescent pour une détection multiple dans un procédé d'amplification isotherme à médiation par boucle et un procédé de diagnostic moléculaire l'utilisant. En particulier, l'ensemble d'amorces a une configuration dans laquelle un agent fluorescent ou un extincteur se lie à chacune des amorces avant et arrière d'une amorce de boucle, des agents différents se liant aux amorces.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2021-0162864 | 2021-11-24 | ||
KR20210162864 | 2021-11-24 | ||
KR10-2022-0158852 | 2022-11-24 | ||
KR1020220158852A KR20230078548A (ko) | 2021-11-24 | 2022-11-24 | 루프-매개 등온 증폭 방법에서 다중 검출을 위한 형광 표지 물질 프라이머 셋트 및 이를 이용한 분자 진단 방법 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2023096373A1 true WO2023096373A1 (fr) | 2023-06-01 |
Family
ID=86540072
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2022/018724 WO2023096373A1 (fr) | 2021-11-24 | 2022-11-24 | Ensemble d'amorces de matériau d'étiquetage fluorescent pour détection multiple dans un procédé d'amplification isotherme à médiation par boucle et procédé de diagnostic moléculaire l'utilisant |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2023096373A1 (fr) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2021009185A1 (fr) * | 2019-07-15 | 2021-01-21 | National University Of Ireland, Galway | Amorces pour amplification isotherme |
-
2022
- 2022-11-24 WO PCT/KR2022/018724 patent/WO2023096373A1/fr unknown
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2021009185A1 (fr) * | 2019-07-15 | 2021-01-21 | National University Of Ireland, Galway | Amorces pour amplification isotherme |
Non-Patent Citations (4)
Title |
---|
ANONYMOUS: "SARS-CoV-2 LAMP diagnostic assay. Version 1", COLOR GENOMICS, INC., 19 May 2020 (2020-05-19), XP093068223, Retrieved from the Internet <URL:https://www.color.com/wp-content/uploads/2020/05/LAMP-Diagnostic-Assay.pdf> [retrieved on 20230727] * |
HIGGINS OWEN, SMITH TERRY J.: "Loop-Primer Endonuclease Cleavage–Loop-Mediated Isothermal Amplification Technology for Multiplex Pathogen Detection and Single-Nucleotide Polymorphism Identification", THE JOURNAL OF MOLECULAR DIAGNOSTICS, AMERICAN SOCIETY FOR INVESTIGATIVE PATHOLOGY AND THE ASSOCIATION FOR MOLECULAR PATHOLOGY, vol. 22, no. 5, 1 May 2020 (2020-05-01), pages 640 - 651, XP093043555, ISSN: 1525-1578, DOI: 10.1016/j.jmoldx.2020.02.002 * |
NURUL NAJIAN A.B.; ENGKU NUR SYAFIRAH E.A.R.; ISMAIL NABILAH; MOHAMED MAIZAN; YEAN CHAN YEAN: "Development of multiplex loop mediated isothermal amplification (m-LAMP) label-based gold nanoparticles lateral flow dipstick biosensor for detection of pathogenicLeptospira", ANALYTICA CHIMICA ACTA, ELSEVIER, AMSTERDAM, NL, vol. 903, 24 November 2015 (2015-11-24), AMSTERDAM, NL , pages 142 - 148, XP029364351, ISSN: 0003-2670, DOI: 10.1016/j.aca.2015.11.015 * |
YU JIA; WANG FEIXUE; ZHAN XIJING; WANG XIN; ZUO FENG; WEI YUXI; QI JUN; LIU YIN: "Improvement and evaluation of loop-mediated isothermal amplification combined with a chromatographic flow dipstick assay and utilization in detection ofVibrio cholerae", ANALYTICAL AND BIOANALYTICAL CHEMISTRY, SPRINGER BERLIN HEIDELBERG, BERLIN/HEIDELBERG, vol. 411, no. 3, 1 December 2018 (2018-12-01), Berlin/Heidelberg, pages 647 - 658, XP036677274, ISSN: 1618-2642, DOI: 10.1007/s00216-018-1472-1 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN112725537A (zh) | 一种检测2019新型冠状病毒的多重实时荧光定量pcr试剂盒、方法及引物探针组合物 | |
CN105934523A (zh) | 核酸的多重检测 | |
CN104685062A (zh) | 使用非干扰性噪音消除性多核苷酸鉴定标签的多重焦磷酸测序 | |
KR102338861B1 (ko) | RT-LAMP를 이용한 코로나바이러스감염증-19을 일으키는 SARS-CoV-2의 검출용 PNA 프로브와 프라이머 및 이를 이용한 감염여부 판별방법 | |
CA3153071A1 (fr) | Systemes, methodes et compositions pour la detection precoce rapide de biomarqueurs d'arn hote d'infection et l'identification precoce d'une infection a coronavirus covid-19 chez les etres humains | |
CN108588252A (zh) | 一种寄生虫检测试剂盒及其检测方法 | |
CN110358815A (zh) | 一种同时检测多个靶标核酸的方法及其试剂盒 | |
WO2016190585A1 (fr) | Procédé et kit de détection d'acide nucléique cible | |
CN110760601B (zh) | 一种同时检测布鲁氏菌、流产衣原体和产气荚膜梭菌的引物组、试剂盒及应用 | |
KR20220024253A (ko) | 신종 코로나바이러스 검출용 고감도 다중 루프매개등온증폭 프라이머 세트 | |
CN108531627A (zh) | 一种用于检测b族链球菌的rpa荧光定量引物对、探针、试剂盒及检测方法 | |
KR102278112B1 (ko) | 특정 인공 뉴클레오타이드 서열을 이용한 위양성 판단용 조성물 및 이를 이용한 위양성 판단 방법 | |
CN113186342B (zh) | 一种18联呼吸道病毒核酸联合检测装置 | |
WO2013122319A1 (fr) | Procédé de détection de gène cible ou mutation associée utilisant une réaction de ligase et réaction d'amplification d'enzyme de coupure | |
KR102516022B1 (ko) | 아프리카돼지열병 및 돼지열병 동시감별 실시간유전자 진단법 | |
WO2021075912A1 (fr) | Ensemble d'amorces pour une réaction d'amplification multi-isotherme à haute sensibilité capable de cribler et de détecter simultanément mycobacterium tuberculosis et des mycobactéries non tuberculeuses | |
WO2023096373A1 (fr) | Ensemble d'amorces de matériau d'étiquetage fluorescent pour détection multiple dans un procédé d'amplification isotherme à médiation par boucle et procédé de diagnostic moléculaire l'utilisant | |
US20230090672A1 (en) | Rapid and sample-specific detection of viral pathogen for pooled testing in large-population screening | |
KR20210103109A (ko) | 열성 질환 원인체 검출용 프라이머 및 프로브 세트, 이를 포함하는 키트 및 이를 이용한 검출 방법 | |
WO2018092998A1 (fr) | Procédé de détection de mutation génétique du virus de la septicémie hémorragique virale | |
EP3885455A1 (fr) | Procédé et kit pour la détection du virus sars-cov-2 dans un échantillon sur la base d'une amplification isotherme à médiation par boucle de transcription inverse (rt-lamp) | |
KR20230078548A (ko) | 루프-매개 등온 증폭 방법에서 다중 검출을 위한 형광 표지 물질 프라이머 셋트 및 이를 이용한 분자 진단 방법 | |
WO2024058300A1 (fr) | Composition de détection du vhsv au moyen de ciseaux géniques et d'une amplification isotherme médiée par boucles, kit et procédé de détection du vhsv l'utilisant | |
CN112126713A (zh) | 一种冠状病毒和流感病毒联合检测产品及其用途 | |
WO2023121335A1 (fr) | Composition pour la détection du syndrome ulcératif épizootique et procédé pour la détection du syndrome ulcératif épizootique |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 22899055 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |